Enter your information to understand your FSH levels.

The History of FSH

The story of FSH begins with German gynecologists Selmar Aschheim and Bernhard Zondek, who in the late 1920s discovered that pituitary and pregnancy-related hormones could trigger dramatic reproductive changes when injected into laboratory animals, work that led directly to the famous Aschheim-Zondek pregnancy test used clinically for decades afterward. Through the 1930s, researchers including Herbert Evans and Joseph Long at Berkeley gradually realized that the pituitary gland actually released two distinct gonadotropic hormones rather than just one, eventually distinguishing follicle-stimulating hormone from its close partner, luteinizing hormone, based on their genuinely different biological effects on the ovaries and testes. The field then advanced enormously in the 1950s and 1960s once Rosalyn Yalow and Solomon Berson developed radioimmunoassay technology, finally making it possible to measure FSH's tiny circulating concentrations precisely enough for practical, everyday clinical use in ordinary patients.

What FSH Actually Is

Follicle-stimulating hormone is produced by the anterior pituitary gland, a small structure at the base of the brain, and travels through the bloodstream to directly stimulate the growth of ovarian follicles in women and sperm production within the testes of men. Its release is carefully controlled by gonadotropin-releasing hormone from the hypothalamus, and it participates in a tightly regulated feedback loop involving estrogen, progesterone, and testosterone, all of which signal back to the brain to fine-tune exactly how much FSH gets released at any given moment. FSH levels rise substantially after menopause, since the ovaries no longer respond adequately to stimulation and no longer produce enough estrogen to signal the brain to reduce its hormone output, making FSH testing genuinely useful for evaluating fertility, ovarian reserve, and menopausal status.

How FSH Is Measured

FSH is measured today using automated chemiluminescent immunoassay platforms, in which laboratory antibodies bind specifically to FSH molecules in a blood sample, generating a measurable light signal directly proportional to the hormone's concentration present in that sample. This modern approach replaced the far more laborious and considerably less precise bioassays used decades earlier, which relied on directly observing physical changes in laboratory animals injected with a patient's blood or urine sample. Because FSH naturally fluctuates throughout the menstrual cycle, doctors typically specify a particular day of the cycle, most often day three, for blood collection to ensure genuinely consistent and clinically meaningful results across different testing occasions.

Scientists Behind the Science

Selmar Aschheim and Bernhard Zondek deserve enormous credit for their pioneering, foundational work connecting pituitary and reproductive hormones to observable, measurable biological effects, research that essentially launched the entire field of clinical reproductive endocrinology as we understand it today. Herbert Evans and his Berkeley colleagues later refined that early foundation considerably, carefully separating FSH from luteinizing hormone as two genuinely distinct pituitary hormones with importantly different physiological roles throughout the reproductive system. Rosalyn Yalow's Nobel Prize-winning radioimmunoassay technique, developed together with Solomon Berson, ultimately made routine FSH testing a practical clinical reality, transforming what had once required live laboratory animals into a simple, fast blood test available in nearly any hospital laboratory today.